The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Johnson & Johnson is increasing its dividend for the 63rd consecutive year. This further cements the healthcare giant's ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

Johnson & Johnson on Tuesday reported better-than-expected first-quarter results and lifted its sales forecast for the full ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms ...

Joaquin Duato; Chairman of the Board, Chief Executive Officer; Johnson & Johnson John Reed; Executive Vice President - Innovative Medicine, Research and Development; Johnson & Johnson Joseph Wolk ...